Sector Gamma As Acadia Pharmaceuticals Inc Transaction History

Sector Gamma As

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$20.78 - $31.77 $173,014 - $264,517	8,326 Added 4.63%	188,111 $5.89 Million
Q3 2023 Nov 06, 2023	SELL	$20.84 - $33.47 $435,785 - $699,891	-20,911 Reduced 10.42%	179,785 $3.75 Million
Q2 2023 Aug 09, 2023	SELL	$17.8 - $25.65 $569,991 - $821,364	-32,022 Reduced 13.76%	200,696 $4.81 Million
Q1 2023 May 12, 2023	BUY	$16.32 - $20.92 $765,130 - $980,792	46,883 Added 25.23%	232,718 $4.38 Million
Q4 2022 Feb 07, 2023	BUY	$14.2 - $18.63 $2.64 Million - $3.46 Million	185,835 New	185,835 $2.96 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

Stay updated on Sector Gamma As with notifications on news.